Search
Patexia Research
Case number IPR2015-01723

Coalition for Affordable Drugs IX, LLC v. Bristol-Myers Squibb Company > Documents

Date Field Doc. No.PartyDescription
Feb 22, 2016 10 board Decision Denying Institution Download
Jan 20, 2016 9 petitioner Petitioner's Updated Mandatory Notice Download
Nov 24, 2015 2001 patent_own Donald J.P. Pinto et al., Factor Xa Inhibitors- Next-Generation Antithrombotic Agents, 53 J. MED. CHEM. 6243, 6243 (2010) Download
Nov 24, 2015 2010 patent_own Bristol-Myers Squibb Co., Quarterly Report (Form 10-Q) (Oct. 27, 2015) Download
Nov 24, 2015 2005 patent_own Donald J.P. Pinto et al., Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo-3,4-c-pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibito Download
Nov 24, 2015 2002 patent_own Pancras C. Wong et al., Apixaban, an Oral, Direct and Highly Selective Factor Xa Inhibitor- In Vitro, Antithrombotic and Antihemostatic Studies, 6 J. THROMBOSIS and HAEMOSTATIS 820 (2008) Download
Nov 24, 2015 2003 patent_own Donald J.P. Pinto et al., Case History- Eliquis (Apixaban), a Potent and Selective Inhibitor of Coagulation Factor Xa for the Prevention and Treatment of Thrombotic Diseases, 47 ANN. REP. MEDICINAL CHEMISTRY 123 (2012) Download
Nov 24, 2015 2007 patent_own Excerpts of File History for U.S. Patent No. 6,967,208 Download
Nov 24, 2015 2008 patent_own Bengt I. Eriksson et al., Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism, 62 ANN. REV. MED. 41 (2011) Download
Nov 24, 2015 2009 patent_own Bristol-Myers Squibb Co., Annual Report (Form 10-K) (Feb. 13, 2015) Download
Nov 24, 2015 8 patent_own Patent Owner's Preliminary Response Download
Nov 24, 2015 2006 patent_own Press Release, American Chemical Society, -Heroes of Chemistry- Developed Products That Improve Health, Homes and Automobiles (June 29, 2015) Download
Nov 24, 2015 2004 patent_own Yun-Long Li et al., Preparation of 1-(3-aminobenzo-d-isoxazol-5-yl)-1H-pyrazolo-4,3-d-pyrimidin-7(6H)-ones as Potent, Selective, and Efficacious Inhibitors of Coagulation Factor Xa, 16 BIOORGANIC and MEDICINAL CHEMISTRY LETTERS 5176 (2006) Download
Oct 22, 2015 7 patent_own Patent Owner Updated Mandatory Notice Download
Sep 2, 2015 5 potential_ Power of Attorney Download
Sep 2, 2015 6 potential_ Related Matters Download
Aug 27, 2015 4 board Notice of Filing Data Accorded to Petition Download
Aug 13, 2015 1009 petitioner Prescribing Information- Eliquis FDA Label Download
Aug 13, 2015 1 petitioner Petition for IPR of 6,967,208 Download
Aug 13, 2015 1003 petitioner PCT Application WO 00/39131 (Fevig I) Download
Aug 13, 2015 1006 petitioner PCT Application WO 95/01980 Download
Aug 13, 2015 1008 petitioner Dec of George Burton Download
Aug 13, 2015 1002 petitioner Excerpts from File History of 6,967,208 Download
Aug 13, 2015 1004 petitioner U.S. 6,413,980 (Fevig II) Download
Aug 13, 2015 2 petitioner POA Download
Aug 13, 2015 3 petitioner Power of Attorney Download
Aug 13, 2015 1001 petitioner U.S. 6,967,208 Download
Aug 13, 2015 1005 petitioner Excerpts from File History of 6,413,980 Download
Menu